Treatment for drug-resistant tuberculosis: Sirturo shows promise, but concerns for patient safety remain
In a viewpoint published in The Lancet, the Community Research Advisors Group ( CRAG ) argue that research into Bedaquiline ( Sirturo ), a new drug, fast tracked for multidrug-resistant tuberculosis ( ...
read article